Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Clinical trial NCT04881240 · RECRUITING

Trial details

NCT number: NCT04881240
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, in Relapse Acute Lymphoblastic Leukemia, Refractory Pediatric ALL

Start date: 2024-02-14
Primary completion: 2027-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.